**Core Concept**
Central serous chorioretinopathy (CSC) is a condition characterized by the accumulation of fluid under the retina, causing a detachment and vision disturbances. The exact cause is unknown, but it is often linked to stress, corticosteroid use, or other factors that increase intraocular pressure.

**Why the Correct Answer is Right**
The treatment of choice for central serous chorioretinopathy is typically observation, as most cases resolve spontaneously. However, if the condition does not improve or if there is a significant decrease in vision, a treatment option is photodynamic therapy (PDT). This involves the use of a light-sensitive medication that is activated by a low-intensity laser, which helps to reduce fluid accumulation and promote healing. The mechanism behind PDT involves the activation of the photosensitizer, which generates reactive oxygen species that damage the surrounding tissue, thereby reducing the accumulation of fluid.

**Why Each Wrong Option is Incorrect**
**Option A:** Corticosteroids can actually exacerbate CSC, as they can increase intraocular pressure and worsen the condition. They are not a suitable treatment for central serous chorioretinopathy.
**Option B:** Laser photocoagulation is not typically used to treat CSC, as it can cause scarring and further damage to the retina.
**Option C:** Vitreoretinal surgery is not usually necessary for treating CSC, as the condition typically resolves without surgical intervention.

**Clinical Pearl / High-Yield Fact**
Corticosteroids should be avoided in patients with central serous chorioretinopathy, as they can worsen the condition and lead to further vision loss.

**Correct Answer: C. Photodynamic therapy. Photodynamic therapy.**